Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial

Stock Trading Ideas

General Motors Q1 Preview: 60% Stock Rally Meets Its Biggest Reality Check
General Motors Q1 Preview: 60% Stock Rally Meets Its Biggest Reality Check
Ligand Bets On Royalty Growth With XOMA Buyout Worth Over $700 Million
Ligand Bets On Royalty Growth With XOMA Buyout Worth Over $700 Million
Verizon Comeback Meets Qualcomm AI Surge: Are Telecom ETFs Back On Investors' Radars?
Verizon Comeback Meets Qualcomm AI Surge: Are Telecom ETFs Back On Investors' Radars?
Ligand Bets On Royalty Growth With XOMA Buyout Worth Over $700 Million
Ligand Bets On Royalty Growth With XOMA Buyout Worth Over $700 Million
Verizon Comeback Meets Qualcomm AI Surge: Are Telecom ETFs Back On Investors' Radars?
Verizon Comeback Meets Qualcomm AI Surge: Are Telecom ETFs Back On Investors' Radars?
CorMedix Eyes $2 Billion Market With Encouraging Data From Fungal Infection Study
CorMedix Eyes $2 Billion Market With Encouraging Data From Fungal Infection Study
Molson Coors Beverage Analyst Cuts Forecasts Ahead Of Q1 Results
Molson Coors Beverage Analyst Cuts Forecasts Ahead Of Q1 Results

Trading Ideas Recent News

EXCLUSIVE: Ross Gerber's Magnificent Seven Rankings — Plus The Outsider Tech Pick He Says Will 'Be A Trillion Dollar Company'
EXCLUSIVE: Ross Gerber's Magnificent Seven Rankings — Plus The Outsider Tech Pick He Says Will 'Be A Trillion Dollar Company'
Ross Gerber ranks his favorite Magnificent Seven stocks for Benzinga and shares another top tech stock pick.
Adobe Stock Is Dropping Today: What's Happening?
Adobe Stock Is Dropping Today: What's Happening?
Adobe shares are under pressure on Monday. Mizuho downgraded the stock from Outperform to Neutral and cut its price target from $315 to $270.
Why Is Sagimet Biosciences Stock Trading Higher On Monday?
Why Is Sagimet Biosciences Stock Trading Higher On Monday?
Sagimet shares surge as Phase 3 acne trial plans and $175M offering fund pipeline through 2028, with technicals showing strong momentum.
United Rentals Bulls Still In Control
United Rentals Bulls Still In Control
United Rentals stock has surged over 30%, and may have further room to run. Here's why momentum remains strong.
Reddit Shares Are Climbing Monday: What's Driving The Action?
Reddit Shares Are Climbing Monday: What's Driving The Action?
Reddit Inc (NYSE:RDDT) shares are trading higher Monday afternoon on a recent data-licensing deal and ahead of Thursday's earnings.
Crude Oil Gains Over 1%; Verizon Posts Upbeat Earnings
Crude Oil Gains Over 1%; Verizon Posts Upbeat Earnings
U.S. stocks trade lower on Monday, with Dow falling 0.1%. Verizon beats Q1 earnings, raises FY26 guidance. European shares mixed, Asian markets close mixed.
EXCLUSIVE | $9 Billion And Counting: GameStop Says It Will 'Be Disciplined' — But Shareholders Are Asking When
EXCLUSIVE | $9 Billion And Counting: GameStop Says It Will 'Be Disciplined' — But Shareholders Are Asking When
GameStop Corp. (NYSE:GME) is sitting on one of the largest cash hoards in retail, and management isn’t in
Eagle Point Credit: The 18% CLO Yield Is Not The Signal — The Equity Tranche Structure Beneath It Is
Eagle Point Credit: The 18% CLO Yield Is Not The Signal — The Equity Tranche Structure Beneath It Is
Newly Listed Veradermics Hair Loss Drug Shows Hair Growth Gains
Newly Listed Veradermics Hair Loss Drug Shows Hair Growth Gains
Veradermics reports Phase 2/3 data for VDPHL01, showing significant hair growth and a safety profile, with shares rising on Monday.
Norfolk Southern Analysts Boost Their Forecasts Following Upbeat Q1 Earnings
Norfolk Southern Analysts Boost Their Forecasts Following Upbeat Q1 Earnings
Norfolk Southern (NYSE:NSC) reported better-than-expected earnings for Q1 despite challenges. Analysts maintain price targets for the stock.
Oruka Therapeutics Stock Explodes As Psoriasis Data Shows 'Highly Compelling' Skin Clearance
Oruka Therapeutics Stock Explodes As Psoriasis Data Shows 'Highly Compelling' Skin Clearance
Oruka Therapeutics shares rise as ORKA-001 shows strong psoriasis clearance rates and durable dosing potential in Phase 2a EVERLAST-A trial.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved